+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Disease Management Apps Market - Global Forecast 2026-2032- Product Image
Disease Management Apps Market - Global Forecast 2026-2032- Product Image
Sale

Disease Management Apps Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6085457
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Disease Management Apps Market is projected to reach USD 11.66 Billion in 2026. It is expected to continue growing at a CAGR of 8.88%, reaching USD 19.51 Billion by 2032.

Disease Management Apps: Executive Overview

Disease management apps support patients and care teams with tools for symptom tracking, medication reminders, remote monitoring, education, appointment coordination, and communication. Their role is expanding as healthcare systems seek more continuous, patient-centered management of chronic conditions while maintaining clinical oversight, privacy, accessibility, and interoperability.

Digital Care Is Shifting Toward Continuous, Connected Management

The landscape is moving from isolated wellness features toward connected care pathways that link patients, clinicians, pharmacies, laboratories, and connected devices. Greater emphasis is being placed on evidence-based workflows, integration with electronic health records, accessible design, reimbursement alignment, and measurable clinical outcomes. Regulatory scrutiny and cybersecurity requirements are also encouraging stronger governance of health data and software-enabled care.

Artificial Intelligence Is Strengthening Personalization and Clinical Support

Artificial intelligence can help disease management apps identify patterns in patient-reported data, personalize reminders, summarize longitudinal information, and support risk stratification. Its responsible use depends on representative training data, transparent validation, human review, explainability, and controls against unsafe recommendations. Applications that augment clinicians and help patients act on reliable information are more sustainable than systems that present unverified automated diagnoses or treatment decisions.

Regional Differences Reflect Infrastructure, Policy, and Care-Delivery Models

North America is characterized by advanced digital-health infrastructure, remote-care adoption, and strong attention to privacy, reimbursement, and clinical validation. Europe emphasizes cross-border data governance, interoperability, accessibility, and public-health integration. Asia-Pacific combines rapid mobile adoption with substantial variation in infrastructure, language, regulation, and urban-rural access. Latin America is shaped by uneven connectivity, fragmented care delivery, and demand for affordable mobile-first services. The Middle East is investing in digital transformation and coordinated care, while the Africa region presents both access constraints and opportunities for low-bandwidth, community-oriented solutions.

Economic and Institutional Groups Shape Adoption Priorities

ASEAN markets commonly prioritize scalable mobile access, multilingual design, and solutions suited to varied health-system maturity. BRICS economies reflect diverse regulatory, infrastructure, and public-private delivery environments, making localization and affordability important. The European Union places particular weight on privacy, interoperability, cybersecurity, and evidence requirements. G7 settings generally have mature clinical institutions and stronger expectations for validation, integration, and patient safety. GCC countries often emphasize nationally coordinated digital-health programs and advanced infrastructure. NATO members span differing health systems but share heightened interest in cybersecurity, resilience, and continuity of care.

Country Context Determines Product Design and Implementation

Australia and Canada require attention to dispersed populations, public-system integration, and remote access. Brazil, Mexico, India, and South Africa benefit from mobile-first approaches that address affordability, language diversity, and uneven connectivity. China, Japan, and South Korea have strong digital engagement but require locally appropriate regulation, platforms, and care workflows. France, Germany, Italy, Spain, and the United Kingdom place substantial emphasis on clinical governance, privacy, reimbursement, and integration with established health services. Russia presents a distinct regulatory and infrastructure environment requiring careful localization. Across the United States, interoperability, payer and provider workflows, privacy, and evidence of patient benefit remain central considerations.

Prioritize Evidence, Interoperability, Equity, and Safe AI

Industry leaders should begin with clearly defined clinical and patient outcomes rather than feature volume. They should build interoperability into the product architecture, establish privacy and cybersecurity controls from the outset, and test usability across age, language, disability, income, and connectivity differences. Partnerships with clinicians, patient organizations, payers, pharmacies, and public-health bodies can improve adoption and accountability. AI deployments should use staged validation, continuous monitoring, human escalation pathways, and clear communication about limitations. Implementation plans should also include training, support, evaluation metrics, and mechanisms for rapid remediation when safety or access problems emerge.

Methodology: Structured Synthesis of Verified Market Drivers

This executive summary uses the defined disease management apps scope and organizes insights across technology, care delivery, regulation, regional conditions, economic groupings, and country contexts. The analysis distinguishes observable structural drivers-such as chronic-care needs, digital connectivity, interoperability, privacy, cybersecurity, and AI governance-from unsupported commercial claims. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific assessments. Conclusions are framed as qualitative implications for strategy and implementation and should be validated against current local regulations, clinical evidence, and stakeholder requirements before use.

Sustainable Growth Depends on Trustworthy, Integrated Patient Support

Disease management apps are becoming more useful when they extend clinical relationships rather than operate as disconnected digital tools. The strongest strategic opportunities lie in trusted data practices, interoperable workflows, inclusive access, clinically meaningful personalization, and responsible AI. Leaders that combine measurable patient value with rigorous governance and local adaptation will be better positioned to support safer, more continuous disease management across diverse health systems.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Disease Management Apps Market, by Platform
7.1. Introduction
7.2. Android Apps
7.3. iOS Apps
7.4. Web-based Apps
8. Disease Management Apps Market, by Revenue Model
8.1. Introduction
8.2. Free Apps
8.3. Pay-Per-Use Apps
8.4. Subscription-Based Apps
9. Disease Management Apps Market, by Device Integration
9.1. Introduction
9.2. Non-Wearables
9.3. Wearables-Enabled
10. Disease Management Apps Market, by End-User
10.1. Introduction
10.2. Caregivers
10.3. Healthcare Professionals
10.4. Insurance Providers
10.5. Patients
11. Disease Management Apps Market, by Indication
11.1. Introduction
11.2. Asthma
11.3. Cardiovascular Issues
11.4. Diabetes
11.5. Mental Health
11.6. Obesity
12. Disease Management Apps Market, by Deployment Model
12.1. Introduction
12.2. Cloud-Based
12.3. On-Premise
13. Disease Management Apps Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Disease Management Apps Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Disease Management Apps Market, by Country
15.1. Introduction
15.2. United States
15.3. Germany
15.4. China
15.5. United Kingdom
15.6. India
15.7. Japan
15.8. Russia
15.9. Brazil
15.10. Canada
15.11. Italy
15.12. Mexico
15.13. France
15.14. Spain
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Ada Health GmbH
17.2. Apple Inc.
17.3. Azumio Inc.
17.4. Bearable Ltd.
17.5. Biofourmis Inc. by ActiGraph, LLC
17.6. Cedar Gate Technologies, Inc.
17.7. Cercacor Laboratories, Inc.
17.8. Clanwilliam Group Ltd.
17.9. Cognizant Technology Solutions Corporation
17.10. Curable, Inc.
17.11. DarioHealth Corp.
17.12. Dexcom, Inc.
17.13. Dimagi, Inc.
17.14. F. Hoffmann-La Roche Ltd.
17.15. HealthEdge Software, Inc.
17.16. Healthy.io Ltd.
17.17. IBM Corporation
17.18. Infosys Limited
17.19. Kaia Health GmbH
17.20. Koninklijke Philips N.V.
17.21. Liva Healthcare A/S
17.22. Medtronic plc
17.23. Microsoft Corporation
17.24. MyFitnessPal, Inc.
17.25. NextGen Healthcare, Inc.
17.26. Omada Health Inc.
17.27. Oracle Corporation
17.28. Teladoc Health, Inc.
17.29. WellDoc, Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Disease Management Apps Market, Years Considered for the Study
FIGURE 2. Global Disease Management Apps Market, Research Design
FIGURE 3. Global Disease Management Apps Market, Research Framework
FIGURE 4. Global Disease Management Apps Market, Data Triangulation
FIGURE 5. Global Disease Management Apps Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Disease Management Apps Market Size, by Platform, 2025 vs 2032 (%)
FIGURE 7. Global Disease Management Apps Market Size, by Platform, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Disease Management Apps Market Size, by Revenue Model, 2025 vs 2032 (%)
FIGURE 9. Global Disease Management Apps Market Size, by Revenue Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Disease Management Apps Market Size, by Device Integration, 2025 vs 2032 (%)
FIGURE 11. Global Disease Management Apps Market Size, by Device Integration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Disease Management Apps Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 13. Global Disease Management Apps Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Disease Management Apps Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 15. Global Disease Management Apps Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Disease Management Apps Market Size, by Deployment Model, 2025 vs 2032 (%)
FIGURE 17. Global Disease Management Apps Market Size, by Deployment Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Disease Management Apps Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Disease Management Apps Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Disease Management Apps Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Disease Management Apps Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Disease Management Apps Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Disease Management Apps Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Disease Management Apps Market Segmentation & Coverage
TABLE 2. Global Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 3. Global Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 4. Global Android Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Android Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Android Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global iOS Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global iOS Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global iOS Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Web-based Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Web-based Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Web-based Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 14. Global Free Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Free Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Free Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Pay-Per-Use Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Pay-Per-Use Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Pay-Per-Use Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Subscription-Based Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Subscription-Based Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Subscription-Based Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 24. Global Non-Wearables Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Non-Wearables Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Non-Wearables Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Wearables-Enabled Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Wearables-Enabled Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Wearables-Enabled Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 31. Global Caregivers Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Caregivers Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Caregivers Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Healthcare Professionals Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Healthcare Professionals Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Healthcare Professionals Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Insurance Providers Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Insurance Providers Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Insurance Providers Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Patients Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Patients Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Patients Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 44. Global Asthma Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Asthma Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Asthma Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Cardiovascular Issues Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Cardiovascular Issues Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Cardiovascular Issues Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Mental Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Mental Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Mental Health Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Obesity Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Obesity Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Obesity Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 60. Global Cloud-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Cloud-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Cloud-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global On-Premise Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global On-Premise Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global On-Premise Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Disease Management Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Disease Management Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 74. North America Disease Management Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. North America Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 76. North America Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 77. North America Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 78. North America Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 79. North America Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 80. North America Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 81. Latin America Disease Management Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Latin America Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 83. Latin America Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 84. Latin America Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 85. Latin America Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 86. Latin America Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 87. Latin America Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 88. Europe Disease Management Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Europe Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 90. Europe Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 91. Europe Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 92. Europe Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 93. Europe Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 94. Europe Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 95. Middle East Disease Management Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Middle East Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 97. Middle East Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 98. Middle East Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 99. Middle East Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 100. Middle East Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 101. Middle East Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 102. Africa Disease Management Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Africa Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 104. Africa Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 105. Africa Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 106. Africa Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 107. Africa Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 108. Africa Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 109. Global Disease Management Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. ASEAN Disease Management Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. ASEAN Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 112. ASEAN Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 113. ASEAN Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 114. ASEAN Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 115. ASEAN Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 116. ASEAN Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 117. GCC Disease Management Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. GCC Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 119. GCC Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 120. GCC Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 121. GCC Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 122. GCC Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 123. GCC Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 124. European Union Disease Management Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. European Union Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 126. European Union Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 127. European Union Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 128. European Union Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 129. European Union Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 130. European Union Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 131. BRICS Disease Management Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. BRICS Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 133. BRICS Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 134. BRICS Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 135. BRICS Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 136. BRICS Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 137. BRICS Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 138. G7 Disease Management Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. G7 Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 140. G7 Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 141. G7 Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 142. G7 Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 143. G7 Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 144. G7 Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 145. NATO Disease Management Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. NATO Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 147. NATO Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 148. NATO Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 149. NATO Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 150. NATO Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 151. NATO Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 152. Global Disease Management Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. United States Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 154. United States Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 155. United States Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 156. United States Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 157. United States Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 158. United States Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 159. United States Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 160. Germany Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 161. Germany Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 162. Germany Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 163. Germany Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 164. Germany Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 165. Germany Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 166. Germany Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 167. China Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 168. China Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 169. China Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 170. China Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 171. China Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 172. China Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 173. China Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 174. United Kingdom Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 175. United Kingdom Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 176. United Kingdom Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 177. United Kingdom Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 178. United Kingdom Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 179. United Kingdom Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 180. United Kingdom Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 181. India Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 182. India Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 183. India Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 184. India Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 185. India Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 186. India Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 187. India Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 188. Japan Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 189. Japan Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 190. Japan Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 191. Japan Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 192. Japan Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 193. Japan Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 194. Japan Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 195. Russia Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 196. Russia Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 197. Russia Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 198. Russia Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 199. Russia Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 200. Russia Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 201. Russia Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 202. Brazil Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 203. Brazil Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 204. Brazil Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 205. Brazil Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 206. Brazil Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 207. Brazil Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 208. Brazil Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 209. Canada Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 210. Canada Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 211. Canada Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 212. Canada Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 213. Canada Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 214. Canada Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 215. Canada Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 216. Italy Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 217. Italy Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 218. Italy Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 219. Italy Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 220. Italy Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 221. Italy Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 222. Italy Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 223. Mexico Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 224. Mexico Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 225. Mexico Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 226. Mexico Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 227. Mexico Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 228. Mexico Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 229. Mexico Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 230. France Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 231. France Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 232. France Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 233. France Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 234. France Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 235. France Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 236. France Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 237. Spain Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 238. Spain Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 239. Spain Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 240. Spain Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 241. Spain Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 242. Spain Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 243. Spain Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 244. Australia Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 245. Australia Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 246. Australia Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 247. Australia Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 248. Australia Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 249. Australia Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 250. Australia Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 251. South Korea Disease Management Apps Market Size, 2017-2032 (USD Million)
TABLE 252. South Korea Disease Management Apps Market Size, by Platform, 2017-2032 (USD Million)
TABLE 253. South Korea Disease Management Apps Market Size, by Revenue Model, 2017-2032 (USD Million)
TABLE 254. South Korea Disease Management Apps Market Size, by Device Integration, 2017-2032 (USD Million)
TABLE 255. South Korea Disease Management Apps Market Size, by End-User, 2017-2032 (USD Million)
TABLE 256. South Korea Disease Management Apps Market Size, by Indication, 2017-2032 (USD Million)
TABLE 257. South Korea Disease Management Apps Market Size, by Deployment Model, 2017-2032 (USD Million)
TABLE 258. Global Disease Management Apps Market Share, by Key Player, 2025
TABLE 259. Global Disease Management Apps Market, Key Experts

Companies Mentioned

  • Ada Health GmbH
  • Apple Inc.
  • Azumio Inc.
  • Bearable Ltd.
  • Biofourmis Inc. by ActiGraph, LLC
  • Cedar Gate Technologies, Inc.
  • Cercacor Laboratories, Inc.
  • Clanwilliam Group Ltd.
  • Cognizant Technology Solutions Corporation
  • Curable, Inc.
  • DarioHealth Corp.
  • Dexcom, Inc.
  • Dimagi, Inc.
  • F. Hoffmann-La Roche Ltd.
  • HealthEdge Software, Inc.
  • Healthy.io Ltd.
  • IBM Corporation
  • Infosys Limited
  • Kaia Health GmbH
  • Koninklijke Philips N.V.
  • Liva Healthcare A/S
  • Medtronic plc
  • Microsoft Corporation
  • MyFitnessPal, Inc.
  • NextGen Healthcare, Inc.
  • Omada Health Inc.
  • Oracle Corporation
  • Teladoc Health, Inc.
  • WellDoc, Inc.

Related Topics

Related Reports

Disease Management Apps - Global Strategic Business Report - Product Image

Disease Management Apps - Global Strategic Business Report

  • Report
  • 232 Pages
  • Global
From
Chronic Disease Management Online Market - Global Forecast 2026-2032 - Product Image

Chronic Disease Management Online Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Kidney Disease Management Software Market - Global Forecast 2026-2032 - Product Image

Kidney Disease Management Software Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Disease Management Apps Market Report 2026 - Product Image

Disease Management Apps Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Chronic Disease Management Market - Global Strategic Business Report - Product Image

Chronic Disease Management Market - Global Strategic Business Report

  • Report
  • 488 Pages
  • Global
From

About the Disease Management Apps Market

Within the context of E-Healthcare, Disease Management Apps are a category of software applications designed to assist individuals in managing their health conditions and to promote better health outcomes. E-Healthcare encompasses various innovative technologies in medical care, including electronic health records (EHRs), telemedicine, health informatics, and mobile health (mHealth) applications. Disease Management Apps specifically fall under the umbrella of mHealth and are accessible via smartphones, tablets, and other mobile devices. These apps provide patients with tools to monitor their disease symptoms, manage treatment schedules, and track medication adherence. Furthermore, they often offer educational content, personalized health tips, and communication features that enable patients to consult healthcare professionals virtually. The integration of Disease Management Apps into healthcare practices aims to support patient self-management, reduce the burden on healthcare systems, and achieve better health outcomes through interactive engagement and real-time data. Notable companies operating in the Disease Management Apps market include Livongo, which offers a data-driven approach for diabetes management; Omada Health, with its digital programs for chronic disease prevention and management; MySugr, specializing in digital diabetes care; and Pear Therapeutics, which develops apps for addiction and other mental health conditions. These companies illustrate the diverse range of applications available to empower patients and facilitate the management of various chronic diseases. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.